Despite extensive research on the pathogenesis of PD, no effective therapy is available to halt this progressive neurodegenerative disorder. One of the major roadblocks for discovering drugs against PD is the unavailability of a true chronic persistent animal model for PD. Therefore, developing a chronic persistent animal model to study the pathogenesis of PD is of paramount importance. Based on our exciting preliminary results, here studies have been proposed from various angles to delineate if simple castration of male mice leads to PD-related nigrostriatal pathologies. First, activation of microglia and astroglia and production of proinflammatory molecules in the nigra play an important role in the pathogenesis of PD. Our studies will indicate if castration leads to the activation of glial cells and the expression of proinflammatory molecules in the nigra of male mice. Second, GDNF supports normal health and viability of dopaminergic neurons and the level of GDNF goes down in the nigra of PD patients. Therefore, we will investigate if castration decreases nigral level of GDNF. Third, it has been shown that in PD patients, nigrostriatal dopaminergic neurons and neurotransmitters disappear. Therefore, we will investigate these nigrostriatal pathologies in castrated mice. Fourth, we will test if castration leads to an impairment of locomotor activities in male mice. In summary, if this project becomes successful, castrated male C57/BL6 mice may be used as a simple toxin-free chronic persistent animal model to study PD-related nigrostriatal pathologies paving the way for easy drug screening against PD.

Public Health Relevance

One of the major roadblocks for discovering drugs against PD is the unavailability of a true chronic persistent animal model for PD. Here we will try to describe a simple toxin-free non-transgenic chronic persistent mouse model to study PD-related pathologies paving the way for easy drug screening against PD. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS071479-01
Application #
7983413
Study Section
Neural Oxidative Metabolism and Death Study Section (NOMD)
Program Officer
Sutherland, Margaret L
Project Start
2010-06-15
Project End
2012-05-31
Budget Start
2010-06-15
Budget End
2011-05-31
Support Year
1
Fiscal Year
2010
Total Cost
$225,000
Indirect Cost
Name
Rush University Medical Center
Department
Neurosciences
Type
Schools of Medicine
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Jana, Arundhati; Modi, Khushbu K; Roy, Avik et al. (2013) Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders. J Neuroimmune Pharmacol 8:739-55
Khasnavis, Saurabh; Ghosh, Anamitra; Roy, Avik et al. (2013) Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase. J Biol Chem 288:20843-55
Corbett, Grant T; Roy, Avik; Pahan, Kalipada (2013) Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapy. J Biol Chem 288:8299-312
Ghosh, Arunava; Corbett, Grant T; Gonzalez, Frank J et al. (2012) Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor ?: implications for late infantile Batten disease therapy. J Biol Chem 287:38922-35
Corbett, Grant T; Roy, Avik; Pahan, Kalipada (2012) Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense. J Immunol 189:1002-13
Roy, Avik; Ghosh, Anamitra; Jana, Arundhati et al. (2012) Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease. PLoS One 7:e38113
Khasnavis, Saurabh; Pahan, Kalipada (2012) Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J Neuroimmune Pharmacol 7:424-35
Jana, Malabendu; Pahan, Kalipada (2012) Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor ?. Neurochem Res 37:1718-29
Jana, Malabendu; Mondal, Susanta; Gonzalez, Frank J et al. (2012) Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-?. J Biol Chem 287:34134-48
Ghosh, Arunava; Pahan, Kalipada (2012) Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders. J Biol Chem 287:27189-203

Showing the most recent 10 out of 11 publications